5220000: Bacitracin (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Antibacterial\Bacitracin

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Antibacterial\Bacitracin

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Cyclic peptide (substance)\Bacitracin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Bacitracin	Is a	médicament antibactérien	false	Inferred relationship	Some
Bacitracin	Is a	Bactericide	false	Inferred relationship	Some
Bacitracin	Is a	classe d'allergènes	false	Inferred relationship	Some
Bacitracin	Is a	allergène médicamenteux	false	Inferred relationship	Some
Bacitracin	Is a	Cyclic peptide (substance)	true	Inferred relationship	Some
Bacitracin	Is a	Antibacterial	true	Inferred relationship	Some
Bacitracin	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Antibacterial (disposition)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Bacitracin A	Is a	False	Bacitracin	Inferred relationship	Some
Zinc bacitracin	Is a	False	Bacitracin	Inferred relationship	Some
Bacitracin C	Is a	False	Bacitracin	Inferred relationship	Some
Bacitracin B	Is a	False	Bacitracin	Inferred relationship	Some
Bacitracin methylene disalicylate	Is a	False	Bacitracin	Inferred relationship	Some
Bacitracin measurement (procedure)	Has measured component (attribute)	False	Bacitracin	Inferred relationship	Some
Bacitracin measurement (procedure)	Component	True	Bacitracin	Inferred relationship	Some	1
Product containing bacitracin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin 50,000units powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bacitracin	Inferred relationship	Some
Bacitracin 500 unit/g cutaneous ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bacitracin	Inferred relationship	Some
Bacitracin ophthalmic preparation	Is a	False	Bacitracin	Inferred relationship	Some
Bacitracin-containing product in ocular dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bacitracin	Inferred relationship	Some
Product containing bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	4
Bacitracin 5000000units powder for injection solution bottle	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bacitracin	Inferred relationship	Some
Product containing bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	2
Product containing bacitracin in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing bacitracin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin-containing product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing bacitracin in topical dosage form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Bacitracin	Inferred relationship	Some
Zinc bacitracin	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Bacitracin	Inferred relationship	Some
Bacitracin C	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Bacitracin	Inferred relationship	Some
Bacitracin B	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Bacitracin	Inferred relationship	Some
Bacitracin A	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Bacitracin	Inferred relationship	Some
Bacitracin methylene disalicylate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	True	Bacitracin	Inferred relationship	Some
Product containing bacitracin and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Product containing bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	4
Product containing bacitracin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin and neomycin and polymyxin B only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Product containing only bacitracin and neomycin and polymyxin B and pramocaine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	4
Product containing only bacitracin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	2
Product containing only bacitracin and hydrocortisone and neomycin and polymyxin B (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	4
Product containing only bacitracin in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing only bacitracin in ocular dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin only product in otic dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing only bacitracin in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing only bacitracin in vaginal dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	1
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bacitracin	Inferred relationship	Some	1
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bacitracin	Inferred relationship	Some	1
Bacitracin 500 unit/g cutaneous ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bacitracin	Inferred relationship	Some	1
Bacitracin 500 unit/g cutaneous ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bacitracin	Inferred relationship	Some	1
Bacitracin- and neomycin- and sulfacetamide-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Product containing only bacitracin and neomycin and sulfacetamide (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Bacitracin- and neomycin- and sulfacetamide-containing product in cutaneous dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Product containing only bacitracin and neomycin and sulfacetamide in cutaneous dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Bacitracin	Inferred relationship	Some	3
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Bacitracin	Inferred relationship	Some	2
Bacitracin 250 unit/g and neomycin sulfate 5 mg/g and sulfacetamide sodium 60 mg/g cutaneous powder	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Bacitracin	Inferred relationship	Some	2

Reference Sets

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
9749017	Bacitracin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
790182018	Bacitracin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
56651000195119	bacitracina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
793231000172118	bacitracine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
71681000195117	Bacitracin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module